McKinley Resources Inc., a leading supplier of active ingredients for skin care and personal care, has partnered with Enantis, a biotechnology company based in Brno, Czech Republic, to distribute Enantis' stabilized fibroblast growth factor 2 (FGF2) across North America and select regions.
Thermally and Biologically Stable Growth Peptide
According to Enantis, this stabilized FGF2 (INCI: sh-Polypeptide-1) addresses a key challenge in formulation: unlike traditional FGF2, it offers enhanced thermal and biological stability. This enables:
a longer shelf life,
easier formulation processes, and
improved performance.
Designed for use in advanced skin care, regenerative medicine and personal care products, it has been dermatologically and clinically tested and shown to reduce wrinkles, maintain hydration and soften skin.
Meeting Demand for Science-driven Solutions
“By combining Enantis’ groundbreaking technology with our deep industry relationships, we’re empowering brands to create products that truly stand out,” said John Oliver, CEO of McKinley Resources Inc.
The collaboration aims to meet the growing demand for stable, science-driven solutions in the beauty and personal care industries.
